Intriguingly, irisin reduced the expression of PRMT3 and ROS production as well as lipogenesis in PA-induced hepatic steatosis; however, the overexpression of PRMT3 reversed the antilipogenesis and anti-inflammatory function of irisin [62] (Figure 2). This evidence concerns the gene FNDC5 and fatty liver disease.